4//SEC Filing
Phillips Andrew John 4
Accession 0001213900-25-052365
CIK 0001821586other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 9:05 AM ET
Size
5.7 KB
Accession
0001213900-25-052365
Insider Transaction Report
Form 4
Phillips Andrew John
Director
Transactions
- Award
Option to Buy
2025-06-05+6,682→ 6,682 totalExercise: $48.83Exp: 2035-06-05→ Class A ordinary shares, par value $0.0001 per share (6,682 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 6,682 Class A Ordinary Shares of the Issuer, which will vest in full the earlier of (i) June 5, 2026 and (ii) the date of the Issuer's next annual general meeting of shareholders, subject to the Reporting Person's continued service to the Issuer.
Documents
Issuer
MoonLake Immunotherapeutics
CIK 0001821586
Entity typeother
Related Parties
1- filerCIK 0001921956
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 9:05 AM ET
- Size
- 5.7 KB